Previous 10 | Next 10 |
home / stock / nicxf / nicxf news
1 Net revenue consists of revenue from collaborations less royalty payments which corresponds to Net profit in the consolidated statements of profit or loss. 2 In the case of a merger by acquisition (fusion par absorption), merger (fusion par création d’une nouvelle sociét...
1 This date is based on projections of increased recruitment which take notably into account the lifting of COVID-19 restrictions in China. 2 Ibid Attachment EN_NCX 470 Market Potential PR_20230710_F
Attachment EN_NCX 470 abstracts presented at WGC2023_20230703_F1
Attachment EN_ZERVIATE China NDA Fastrack PR_20230428
Press Release Transfer of Nicox’s shares to Euronext Growth Paris effective on April 28, 2023 April 26, 2023 – release at 9:00 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced th...
Attachment EN_ARVO 2023 PR_F_20230426
1 Net revenue consists of revenue from collaborations less royalty payments which corresponds to Net profit in the consolidated statements of profit or loss. 2 In the case of a merger by acquisition (fusion par absorption), merger (fusion par création d’une nouvelle sociét...
Attachment EN_OcumensionZERVIATEChinaNDASubmission PR_20230414
Attachment EN_NCX 470 Presentations WGC 2023 PR_20230321_F
CONSOLIDATED STATEMENTS OF PROFIT OR LOSS (1) Includes in 2022 an additional non-cash adjustment on NCX 4251 fair value, decreasing by €(10.9) million due to the decision to seek a partner to pursue the development of NCX 4251 in the U.S. Includes in 2021 two non...
News, Short Squeeze, Breakout and More Instantly...
Nicox SA Company Name:
NICXF Stock Symbol:
OTCMKTS Market:
Attachment EN_DenaliLastUSPatient_PR_FINAL
Attachment EN_Nicox Conferences 2024_FINAL
1 Net revenue consists of revenue from collaborations less royalty payments 2 Intra-ocular pressure Attachment EN_Q22024Results_PR_FINAL